Abcellera Biologics Stock Performance Overview
- Last closing price: USD 11.28
- 24‑hour change: +4.53 % (ended 08:58 PM Central Europe, Thursday 22)
- Shares outstanding: 323.7 million
- Market capitalization: USD 3.8 billion
- Volume traded in last 24 hours: USD 39.2 million
- Year‑to‑date trend: -3.24 % since the previous month‑end
- 200‑day simple moving average: USD 6.56
- 52‑week high: USD 15.02 (30 September 2026)
- 52‑week low: USD 2.74 (5 February 2026)
Comparative 24‑Hour Performance of Related Stocks
| Ticker | 24‑hour change | Current price (CAD) | Market cap (CAD) | P/E ratio |
|---|---|---|---|---|
| CG.TO (Centerra Gold) | +0.32 % | 28.58 | 6.1 billion | 6.88 |
| TA.TO (Transalta) | +2.63 % | 17.62 | 6.0 billion | – |
| DOO.TO (Brp /Ca) | –0.28 % | 81.57 | 5.6 billion | 49.91 |
| NPI.TO (Northland Power) | +1.41 % | 22.05 | 5.9 billion | – |
| GEI.TO (Gibson Energy) | +1.02 % | 32.95 | 5.8 billion | 33.55 |
Recent Corporate Actions and Developments
Centerra Gold (CG.TO)
- Corporate update: Announcement of a new senior management team for tungsten projects in Nevada.
- Key appointments:
- David Hendriks – Chief Operating Officer, former mining operations experience at Centerra Gold and other global mines.
- Ron Espell – Vice‑President of Environment & Permitting, with extensive environmental management and regulatory compliance background.
- Strategic focus: Advancement of Pilot Mountain and Tempiute projects toward production, emphasizing operational leadership and environmental oversight to support domestic tungsten production.
Transalta (TA.TO)
- Corporate update: Lodestone Energy disclosed a capital‑raising offer to fund expansion of its solar farm portfolio.
- Capital‑raising details:
- Target: Up to USD 100 million, minimum USD 75 million required.
- Use of proceeds: New farm construction, development of a mass‑market retail electricity service, and general corporate purposes.
- Strategic context: Expansion from five operational farms (since 2019) to 16–18 farms by FY 32, aiming for >800 GWh annual generation.
Brp /Ca (DOO.TO), Northland Power (NPI.TO), Gibson Energy (GEI.TO)
- No significant corporate actions reported within the last 24 hours.
Company Background – Abcellera Biologics
- Industry: Pharmaceutical, health care sector.
- Headquarters: Vancouver, Canada.
- Core capabilities: Discovery and development of next‑generation therapeutic antibodies.
- Technology portfolio: Proprietary immunizations, microfluidics, high‑throughput imaging, genomics, computation, laboratory automation.
- Market listing: Nasdaq stock exchange.
- Website: www.abcellera.com
This article provides a concise, fact‑based snapshot of Abcellera Biologics’ recent trading activity, comparative performance of related Canadian stocks, and notable corporate developments affecting those companies.
